1
|
Orrù G, Mameli A, Demontis C, Rossi P, Ratto D, Occhinegro A, Piras V, Kuqi L, Berretta M, Taibi R, Scano A, Coni P. Oral human papilloma virus infection: an overview of clinical-laboratory diagnosis and treatment. Eur Rev Med Pharmacol Sci 2020; 23:8148-8157. [PMID: 31599444 DOI: 10.26355/eurrev_201909_19035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The aim of this review is to describe the "hot points" of current clinical governance for oral HPV comprising the use of new diagnostic molecular procedures, namely, Pyrosequencing and Next Generation Sequencing. MATERIALS AND METHODS The data on oral HPV was collected through two levels of research. First for all, we used the canonical medical search engines, PubMed, and Medline, followed by the study of current commercial tools for HPV diagnosis, particularly within commercial companies involved in the molecular procedures for HPV detecting and genotyping. RESULTS Different medical procedures are now described and used throughout the world in HPV diagnosis and treatment. However, the laboratory methods are often validated and used for genital infections, and, in these cases, data are missing in the literature as regards the clinical approach for oral lesions. CONCLUSIONS Dental care units are often the front line for a clinical evaluation of a possible HPV lesion in the oral cavity, which means that correct clinical governance could avoid a viral neoplastic progression of this disease with great advantages for the patient. In this case, the problem is due to the difficulty in lesion recognition but also and more especially the absence of correct laboratory diagnosis and subsequent treatment in the clinical course.
Collapse
Affiliation(s)
- G Orrù
- Department of Surgical Sciences, Molecular Biology Service (MBS), University of Cagliari, Cagliari, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Fakhfakh S, Pouliquen C, Campagna J, Loverde K, Treacy P, Maubon T, Rybikowski S, Cambon S, Nguyen L, Deguibert J, Laurent M, Aveno J, Bokor E, Demontis C, Forestier C, Bereni F, Galland J, Montoya C, Mejri I, Cea C, Faucher M, Mokart D, Pignot G, Walz J. Patient care pathway hypnosedation in endo urology: An innovative alternative to general anesthesia. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34225-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
3
|
Spinas E, Generali L, Mameli A, Demontis C, Martinelli D, Giannetti L. Delayed tooth replantation and inflammatory root resorption in childhood and adolescence. J BIOL REG HOMEOS AG 2019; 33:623-627. [PMID: 30945526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Avulsion of one or more permanent teeth represents an emergency in dentistry. The main treatment is the replantation of the tooth/teeth as soon as possible to decrease possible complications. However, this is not always possible, and, in many cases, the patient undergoes a delayed replantation and subsequently prosthetic and implant treatments.
Collapse
Affiliation(s)
- E Spinas
- Department of Surgical Sciences, Sports Dental Research Center, University of Cagliari, Cagliari, Italy
| | - L Generali
- Department of Surgical Sciences, Pedodontics Division, University of Modena-Reggio, Modena, Italy
| | - A Mameli
- Department of Surgical Sciences, Sports Dental Research Center, University of Cagliari, Cagliari, Italy
| | - C Demontis
- Department of Surgical Sciences, Sports Dental Research Center, University of Cagliari, Cagliari, Italy
| | - D Martinelli
- Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti and Pescara, Chieti, Italy
| | - L Giannetti
- Department of Surgical Sciences, Pedodontics Division, University of Modena-Reggio, Modena, Italy
| |
Collapse
|
4
|
Orrù G, Muggironi F, Mameli A, Demontis C, Arcadu B, Scano A, Denotti G, Piras V, Girometta C, Zeza B, Pilloni A. BAX Gene Overexpression in the Tongue Could Warn of Infection Risk due to Periodontal Pathogens. Open Dent J 2018. [DOI: 10.2174/1874210601812011070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Background:
Different host proteins play a central role in cell response during bacterial infections, the Bcl-2-Associated X protein (BAX) and Vascular Cell Adhesion Protein 1 (VCAM-1) are often reported in infective primary events during cell injury.
Objective:
The aim of this study is to evaluate the predictive value of these two proteins as biomarkers of oral bacterial infection, with particular emphasis on the tongue, which plays an important role in microbial homeostasis in the mouth.
Methods:
Twenty-nine patients were recruited and divided according to the Periodontal Index (CPI), 4 of them were severely compromised periodontal patients. Oral hygiene, gingival tissues and plaque presence were evaluated clinically. The laboratory analysis carried out on tongue tissue included: total bacterial genomes, proportion of specific periopathogens and BAX -VCAM-1 expression rate, while Reactive Oxygen Species (ROS) were measured in saliva.
Results:
Neither tongue microbiological status nor salivary ROS level corresponded with the state of disease. VCAM-1 mRNA expression rate was comparable in all patients but, on the contrary, BAX expression resulted high in periodontally-compromised patients and appears related to periodontal status in the analyzed subjects.
Conclusion:
This preliminary work suggests that the BAX protein is a possible candidate in a prognostic marker study for oral diseases started by periodontal bacteria. For example, none of the evaluated clinical and microbiological parameters could predict the presence, prognosis or recurrence of periodontal diseases. This biomarker could be a valuable tool in determining the risk, diagnosis and prognosis of this human illness.
Collapse
|
5
|
Orrù G, Demontis C, Mameli A, Tuveri E, Coni P, Pichiri G, Coghe F, Rosa A, Rossi P, D'hallewin G. The Selective Interaction of Pistacia lentiscus Oil vs. Human Streptococci, an Old Functional Food Revisited with New Tools. Front Microbiol 2017; 8:2067. [PMID: 29114245 PMCID: PMC5660700 DOI: 10.3389/fmicb.2017.02067] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2017] [Accepted: 10/09/2017] [Indexed: 11/13/2022] Open
Abstract
Pistacia lentiscus berry oil (LBO) represents a typical vegetal product of the Mediterranean basin that has been formally used in traditional cuisine for 100s of years. In addition to its interesting alimentary properties, this product could represent an interesting candidate in the field of research on the study of new anti-infective agents. In fact, in Mediterranean countries, lentisk oil still continues to be widely used in folk medicine for oral and skin affections, in particular, acute gingivitis, pediatric skin infections such as impetigo and foot plaques, and biofilm related infections often associated with Streptococcus spp. Following these observations, we have hypothesized a “lentisk oil-bacteria” interaction, placing particular emphasis on the different Streptococcal species involved in these oral and skin diseases. In accordance with this hypothesis, the use of standard antimicrobial-antibiofilm methods (MIC, MBC, MBIC) allowed the interesting behavior of these bacteria to be observed and, in this context, the response to lentisk oil appears to be correlated with the pathogenic profile of the considered microorganism. Two probiotic strains of S. salivarius K12/M18 appeared to be non-sensitive to this product, while a set of five different pathogenic strains (S. agalactiae, S. intermedius, S. mitis, S. mutans, S. pyogenes) showed a response that was correlated to the fatty acid metabolic pathway of the considered species. In fact, at different times of bacteria development, selective High Performance Liquid Chromatography analysis of the growth medium containing LBO detected a significant increase in free unsaturated fatty acids (UFAs) in particular oleic, palmitic and linoleic acids, which are already known for their antibacterial activity. In this context, we have hypothesized that LBO could be able to modulate the pathogen/probiotic rate in a Streptococcal population using the fatty acid metabolic pathway to help the probiotic strain. This hypothesis was strengthened by performing antibacterial testing with oleic acid and an in silico evaluation of the Streptococcal MCRA protein, an enzyme involved in the production of saturated fatty acids from UFA. These results show that LBO may have been used in ancient times as a “natural microbial modulating extract” in the prevention of biofilm- associated diseases.
Collapse
Affiliation(s)
- Germano Orrù
- Molecular Biology Service, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - Cristina Demontis
- Molecular Biology Service, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - Antonello Mameli
- Molecular Biology Service, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - Enrica Tuveri
- Molecular Biology Service, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - Pierpaolo Coni
- Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - Giuseppina Pichiri
- Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - Ferdinando Coghe
- University Hospital Laboratory Services, Azienda Ospedaliero-Universitaria di Cagliari, Cagliari, Italy
| | - Antonella Rosa
- Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
| | - Paola Rossi
- Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy
| | | |
Collapse
|
6
|
Barni S, Ionta MT, Labianca R, Zaniboni A, Ardizzoia A, Massidda B, Tondini C, Capra D, Demontis C, Cazzaniga ME. Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Barni
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - M. T. Ionta
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - R. Labianca
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - A. Zaniboni
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - A. Ardizzoia
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - B. Massidda
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - C. Tondini
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - D. Capra
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - C. Demontis
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| | - M. E. Cazzaniga
- Treviglio Hospital, Treviglio, Italy; University of Cagliari, Cagliari, Italy; Ospedali Riuniti, Bergamo, Italy; Casa di Cura poliambulanza, Brescia, Italy; San Gerardo Hospital, Monza, Italy
| |
Collapse
|